What is Rezolute Inc (RZLT) stock price today?

Rezolute Inc (RZLT) currently trades at $3.20 per share. The stock has a market capitalization of $293.79M and a P/E ratio of —x.

Is RZLT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Rezolute Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 3.64.

Is Rezolute Inc financially healthy?

Rezolute Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 3.64 places it in the safe zone.

RZLT

Rezolute Inc

NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY

$3.20

+2.56% today

Updated 2026-04-30

Market cap

$293.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.93

Dividend yield

—

52W range

$1 – $11

Volume

2.4M

Market cap

$293.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.93

Dividend yield

—

52W range

$1 – $11

Volume

2.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

3.6

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$5.12

+60.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy6 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 3.64 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-20.32M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-41.06M	$-51.79M	$-68.46M	$-74.41M	$-22.77M
EPS	—	—	—	—	$-0.93
Free cash flow	$-39.77M	$-44.63M	$-57.37M	$-69.08M	$-20.32M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RZLT	$293.79M	27	4.3	3.0	5.0	8.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Rezolute Inc trades at $3.20. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.64, it sits in the safe zone.

Frequently asked questions

What is Rezolute Inc's stock price?

Rezolute Inc (RZLT) trades at $3.20.

Is Rezolute Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Rezolute Inc (RZLT)?

The analyst target price is $5.12, representing +60.0% upside from the current price of $3.20.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

3.64 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.rezolutebio.com

Quick metrics

P/S ratio—

ROE-74.00%

Beta0.66

50D MA$3.17

200D MA$5.68

Shares out0.10B

Float0.07B

Short ratio—

Avg volume2.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RZLT vs LLY →RZLT vs JNJ →RZLT vs ABBV →Stock screener →